Vir Biotechnology Inc (VIR)
12.48
+4.59
(+58.17%)
USD |
NASDAQ |
Jan 08, 16:00
12.52
+0.04
(+0.32%)
After-Hours: 20:00
Vir Biotechnology SG&A Expense (Quarterly): 25.74M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Janux Therapeutics Inc | 17.67M |
| Biomarin Pharmaceutical Inc | 253.50M |
| Arbutus Biopharma Corp | 4.537M |
| GlycoMimetics Inc | 4.006M |
| FibroGen Inc | 17.55M |